Correlation Between ZyVersa Therapeutics and MEI Pharma
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and MEI Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and MEI Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and MEI Pharma, you can compare the effects of market volatilities on ZyVersa Therapeutics and MEI Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of MEI Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and MEI Pharma.
Diversification Opportunities for ZyVersa Therapeutics and MEI Pharma
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between ZyVersa and MEI is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and MEI Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MEI Pharma and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with MEI Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MEI Pharma has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and MEI Pharma go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and MEI Pharma
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the MEI Pharma. In addition to that, ZyVersa Therapeutics is 2.59 times more volatile than MEI Pharma. It trades about -0.08 of its total potential returns per unit of risk. MEI Pharma is currently generating about 0.0 per unit of volatility. If you would invest 292.00 in MEI Pharma on August 27, 2024 and sell it today you would lose (14.00) from holding MEI Pharma or give up 4.79% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. MEI Pharma
Performance |
| Timeline |
| ZyVersa Therapeutics |
| MEI Pharma |
ZyVersa Therapeutics and MEI Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and MEI Pharma
The main advantage of trading using opposite ZyVersa Therapeutics and MEI Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, MEI Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEI Pharma will offset losses from the drop in MEI Pharma's long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| MEI Pharma vs. Kezar Life Sciences | MEI Pharma vs. Vincerx Pharma | MEI Pharma vs. Avenue Therapeutics | MEI Pharma vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |